Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate.

The relative ability of phenytoin, ethosuximide and valproate to prevent minimal (clonic) threshold, maximal (tonic extension of the hindlimbs) threshold and supramaximal (tonic extension of the hindlimbs) seizures elicited by electrical and chemical (Metrazol, bicuculline, and picrotoxin) stimulation was determined. Ethosuximide and valproate were effective against minimal (clonic) threshold seizures, whereas phenytoin was ineffective and even activated them. All three anticonvulsants were effective against maximal (tonic extension of the hindlimbs) threshold seizures. Phenytoin and valproate, but not ethosuximide, were effective against supramaximal (tonic extension of the hindlimbs) seizures. The results suggest that the specificity of experimental models of epilepsy used in the evaluation of potential antiepileptic drugs is primarily due to the intensity rather than the nature of the stimulus used or the kind of seizure component evoked. Models based only on maximal (tonic extension of the hindlimbs) threshold seizures may identify anticonvulsant activity, but do not differentiate between substances that prevent seizure spread and those that increase seizure threshold.

• Publication year

  1985

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1985-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(25)20907-7PMID 3919174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.

  1984cited by this paper
• gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.

  1982cited by this paper
• Relationship between pentylenetetrazol-induced seizures and brain pentylenetetrazol levels in mice.

  1980cited by this paper
• Differential antagonisms of anticonvulsants to various components of maximal seizures induced by electroshock or pentylenetetrazol in mice.

  1980cited by this paper
• Antiepileptic Drug Development: I. History and a Program for Progress

  1978cited by this paper
• Antiepileptic Drug Development: II. Anticonvulsant Drug Screening

  1978cited by this paper
• Laboratory evaluation of antiepileptic drugs. Review of laboratory methods.

  1969cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• Effects of variations in stimulus intensity on maximal electroshock seizure pattern, recovery time, and anticonvulsant potency of phenobarbital in mice.

  1956cited by this paper
• Evaluation of Five Methods for Testing Anticonvulsant Activities

  1954cited by this paper
• Comparison of maximal seizures evoked by pentylenetetrazol (metrazol) and electroshock in mice, and their modification by anticonvulsants.

  1953cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper
• Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern.

  1952cited by this paper
• Properties of maximal seizures, and their alteration by anticonvulant drugs and other agents.

  1946cited by this paper

• The Pharmacokinetic and Pharmacodynamic Relationship of Clinically Used Antiseizure Medications in the Maximal Electroshock Seizure Model in Rodents

  2025cites this paper
• The contribution of NaV1.6 to the efficacy of voltage‐gated sodium channel inhibitors in wild type and NaV1.6 gain‐of‐function (GOF) mouse seizure control

  2024cites this paper
• Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis

  2024cites this paper
• Disruption of adenosine metabolism increases risk of seizure‐induced death despite decreased seizure severity

  2024cites this paper
• Automatic and manual segmentation of the piriform cortex: Method development and validation in patients with temporal lobe epilepsy and Alzheimer's disease

  2023cites this paper
• NaV1.6 inhibition drives the efficacy of voltage-gated sodium channel inhibitors to prevent electrically induced seizures in both wild type and Scn8aN1768D/+ gain-of-function mice

  2023cites this paper
• Exploring new cyclohexane carboxamides based GABA agonist: Design, synthesis, biological evaluation, in silico ADME and docking studies.

  2023cites this paper
• Translational Considerations in the Development of Intranasal Treatments for Epilepsy

  2023cites this paper
• A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval

  2022cites this paper
• A companion to the preclinical common data elements for phenotyping seizures and epilepsy in rodent models. A report of the TASK3‐WG1C: Phenotyping working group of the ILAE/AES joint translational task force

  2022cites this paper
• Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.

  2022cites this paper
• Lemon Balm (Melissa officinalis) Essential Oil Moderately Affects Strychnine-Induced and Pentylenetetrazol-Induced Convulsions —In Silico and In Vivo Studies

  2022cites this paper
• Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

  2022cites this paper
• Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.

  2022cites this paper
• Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program

  2021cites this paper
• Synthesis, Molecular Modelling Study of the Methaqualone Analogues as Anti-Convulsant Agent with Improved Cognition Activity and Minimized Neurotoxicity

  2021cites this paper
• Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

  2021cites this paper
• Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion.

  2021cites this paper
• NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats

  2021cites this paper
• Continuous Seizure Emergency Evoked in Mice with Pharmacological, Electrographic, and Pathological Features Distinct from Status Epilepticus

  2021influential citation
• Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation

  2021cites this paper
• Pharmacokinetic and pharmacodynamic analysis of (2S,3S)‐sec‐butylpropylacetamide (SPD) in rats and pigs—A CNS‐active stereoisomer of SPD

  2020cites this paper
• Design, synthesis and docking studies of novel benzopyrone derivatives as anticonvulsants.

  2020cites this paper
• Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

  2020cites this paper
• Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition.

  2019cites this paper
• Ameliorative Effects of Ellagic Acid on Maximal Electroshock and Pentylenetetrazole-Induced Seizures in Mice

  2019cites this paper
• A predictive index of biomarkers for ictogenesis from tier I safety pharmacology testing that may warrant tier II EEG studies.

  2018cites this paper
• A study of effect of acute and chronic administration of aqueous extract of Calotropis procera leaves on maximal electroshock induced seizures in rats

  2017cites this paper
• Effects of small conductance calcium activated potassium channel agonists on seizure like events in in vitro slices and slice cultures

  2017cites this paper
• An experimental study to evaluate the anticonvulsant activity of SSRI ( Fluoxetine , Citalopram ) and SNRI ( Venlafaxine ) in albino mice

  2015cites this paper
• Genetic background of mice strongly influences treatment resistance in the 6 Hz seizure model

  2015cites this paper
• Genetic background ofmice strongly influences treatment resistance in the 6 Hz seizuremodel

  2015cites this paper
• Defining the mechanistic role of high mobility group box-1 and its utility as a biomarker in the inflammatory pathogenesis of epilepsy

  2015cites this paper
• CNS depressant and anticonvulsant activities of the alcoholic extract of leaves of Ziziyphus nummularia.

  2014cites this paper
• Small-Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection and Favorable Drug-Like Properties

  2014cites this paper
• EVALUATION OF ANTIEPILEPTIC AND MEMORY RETENTION ACTIVITY OF CURCUMIN PER SE AND IN COMBINATION WITH ANTIEPILEPTIC DRUGS.

  2013cites this paper
• Synthesis and In-vivo Anti-convulsant Activity of Prodrug of 3-Alkylglutamic Acid in Albino Rats

  2012cites this paper
• ANTICONVULSANT ACTIVITY OF MORINGA OLEIFERA L EAF

  2011cites this paper
• Anti-nociceptive, anxiolytic and anticonvulsant effects of an aqueous leaf extract of Leea guineensis G. Don (Family: Leeaceae)

  2011cites this paper
• Mechanisms of action of antiepileptic drugs.

  2010cites this paper
• Anticonvulsant activity of DNS II fraction in the acute seizure models.

  2010cites this paper
• The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs.

  2009cites this paper
• Antiepileptic Drug Discovery

  2009cites this paper
• Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice.

  2007cites this paper
• Activity profile of pregabalin in rodent models of epilepsy and ataxia.

  2006cites this paper
• Synthesis of N4-(2,4-dimethylphenyl) semicarbazones as 4-aminobutyrate aminotransferase inhibitors.

  2006cites this paper
• Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.

  2006cites this paper
• Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.

  2004cites this paper
• Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles.

  2004cites this paper
• Synthesis and anticonvulsant activity of enaminones. Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates and their corresponding 5-methylcyclohex-2-enone derivatives.

  2003cites this paper
• Assessment of the seizure susceptibility of Wistar Audiogenic rat to electroshock, pentyleneterazole and pilocarpine.

  2003cites this paper
• An anticonvulsant profile of the ketogenic diet in the rat.

  2002cites this paper
• Synthesis and anticonvulsant activity of enaminones. 4. Investigations on isoxazole derivatives.

  2002cites this paper
• Anticonvulsant Profile and Teratogenicity of N‐methyl‐tetramethylcyclopropyl Carboxamide: A New Antiepileptic Drug

  2002cites this paper
• Anticonvulsant Profile of Valrocemide (TV1901): A New Antiepileptic Drug

  2001cites this paper
• Preclinical evaluation of CHF3381 as a novel antiepileptic agent.

  2001cites this paper
• Benzo[b]pyranols and related novel antiepileptic agents.

  2000cites this paper
• Focal microinjection of carbachol into the periaqueductal gray induces seizures in the forebrain of the rat.

  2000cites this paper
• Animal Models of Epilepsy and Epileptic Seizures

  1999cites this paper
• Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants.

  1999cites this paper
• Synthesis, physicochemical properties, anticonvulsant activities and voltage-sensitive calcium channels affinity of N-substituted amides of alpha-(4-phenylpiperazino)-GABA. Part 3: Search for new anticonvulsant compounds.

  1999cites this paper
• Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge

  1999cites this paper
• Rimcazole, a sigma receptor ligand, and the anticonvulsive action of conventional antiepileptic drugs

  1998cites this paper
• Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.

  1998cites this paper
• Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern

  1998cites this paper
• Synthesis, characterization, and anticonvulsant activity of enaminones. Part 5: investigations on 3-carboalkoxy-2-methyl-2,3-dihydro-1H-phenothizin-4[10H]-one derivatives.

  1998cites this paper
• Anticonvulsant activity of 4-urea-5,7-dichlorokynurenic acid derivatives that are antagonists at the NMDA-associated glycine binding site.

  1998cites this paper
• Preclinical evaluation of PNU-151774E as a novel anticonvulsant.

  1998cites this paper
• Phenytoin’s effect on the spread of seizure activity in the amygdala kindling model

  1997cites this paper
• Profile of SB‐204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures

  1997cites this paper
• Clinical Significance of Animal Seizure Models and Mechanism of Action Studies of Potential Antiepileptic Drugs

  1997cites this paper
• Spiranes 6. Ring A homologues of N-benzyloxy-2-azaspiro[4.4]nonane-1,3-dione. Synthesis, X-ray analysis and anticonvulsant evaluation.

  1996cites this paper
• The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models

  1995cites this paper
• Unsaturated analogues of valproic acid : structure activity relationships and interaction with gaba metabolism

  1995cites this paper
• Synthesis and anticonvulsant activity of enaminones. 3. Investigations on 4'-, 3'-, and 2'-substituted and polysubstituted anilino compounds, sodium channel binding studies, and toxicity evaluations.

  1995cites this paper
• Review of the Mechanisms of Action of Antiepileptic Drugs

  1995cites this paper
• Developments in anticonvulsants.

  1995cites this paper
• Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.

  1994cites this paper
• Stimulation-dependent effect of antiepileptic drugs in amygdala kindled rats on both seizure score and duration of afterdischarges.

  1994cites this paper
• Anticonvulsant action of tiagabine, a new GABA-uptake inhibitor

  1994cites this paper
• Inhaled 1,1,1-trichloroethane-produced physical dependence in mice: effects of drugs and vapors on withdrawal.

  1993cites this paper
• N-sulfonyl derivatives of 6,7-dichloro 3,4-dihydro-3-oxo-quinoxalinecarboxylate as glycine-site NMDA and AMPA antagonists

  1993cites this paper
• 3-alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents.

  1992cites this paper
• Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake.

  1992cites this paper
• Strategies for identifying and developing new anticonvulsant drugs

  1992cites this paper
• Properties of the convulsive threshold determined by direct cortical stimulation in rats.

  1992cites this paper
• 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase.

  1991cites this paper
• Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats.

  1991cites this paper
• Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo.

  1991cites this paper
• Effect of ethanol dependence on GABAA antagonist-induced seizures and agonist-stimulated chloride uptake.

  1991cites this paper
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models.

  1991cites this paper
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models.

  1991cites this paper
• Pharmacology of Cl‐966: A potent GABA uptake inhibitor, in vitro and in experimental animals

  1990cites this paper
• Mechanisms of antiepileptic drug action.

  1990cites this paper
• Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy.

  1990cites this paper
• Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.

  1990cites this paper
• Loreclezole (R 72 063): An anticonvulsant chemically unrelated to prototype antiepileptic drugs

  1990cites this paper
• Antiepileptic Drug Development Program: A Cooperative Effort of Government and Industry

  1989cites this paper
• Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate.

  1989cites this paper
• Anticonvulsant effects of a novel aminobenzamide (LY201116) in mice.

  1988cites this paper